Based on the transcriptome profiles of human GBM (Figs 5 and 6), we hypothesized that GBM cell-derived MAP4K1 modulates the expression and secretion of various cytokines and chemokines to retrain the immune responses in the microenvironment of malignant gliomas. This evidence concerns the gene MAP4K1 and glioblastoma.